Loading…
Fierce Virtual Series: JPM Week 2021 has ended
avatar for Susan S. Night

Susan S. Night

TD2
Vice President, Site Engagement and Network Strategy
Susan S. Night, JD, LLM is Vice President of Site Engagement and Network Strategy for Translational Drug Development (TD2), a precision oncology CRO. Before joining TD2, Ms Night served as Director, Research Optimization for US Oncology Research/McKesson Specialty Health. She started her career as a healthcare management consultant with Deloitte. She holds a B.S. in Microbiology from University of Oklahoma, a JD from St. Mary’s University School of Law and an LL.M in health law from University of Houston Law Center.

My Speakers Sessions

Monday, January 11
 

2:00pm EST

 
  • Timezone
  • Filter By Date Fierce Virtual Series: JPM Week 2021 Jan 11-13, 2021
  • Filter By Type
  • Interviews
  • Keynote
  • Networking
  • Panel Discussions
  • Presentations